Table 1.

Subject Demographics Information for Postmortem Brain Tissue That was Used in the Study

Pair	ID	Age	Gender	RIN	PMI (hours)	Toxicology	Tissue preservation	Matter type used for qPCR
Controls
1	AN14757	24	M	7.8	21.33		Frozen	WM
2	AN07176	21	M	7.6	29.91		Frozen	WM, GM
3	AN07444	17	M	6.1	30.75	Sertraline	Frozen	WM
4	5408	6	M	5.8	16		Frozen	WM
5	4848	16	M	7.5	15		Frozen	WM, GM
6	5342	22	M	8.0	14		Frozen	WM, GM
7	5079	33	M	5.3	16	Ethanol	Frozen	WM, GM
8	M3231M	37	M	4.9	24		Frozen	WM, GM
9	AN12137	31	M	4.5	32.92		Frozen	WM, GM
10	AN03217	19	M	5.3	18.58		Frozen	WM, GM
11	AN00544	17	M	5.8	28.92		Frozen	WM, GM
12	AN17425	16	M	6.8	26.16		Frozen	WM, GM
13	4590	20	M	6.8	19		Frozen	WM, GM
14	4670	4	M	6.2	17		Frozen	WM, GM
17	4787	12	M	5.7	15	Montelukast, Albuterol, Prednisone, Loratidine	Frozen	GM
18	1105	16	M	7.8	17		Frozen	GM
19	4334	12	M	5.7	15		Frozen	GM
	Mean	19.24		6.3	20.97
	SEM	2.12		0.3	1.56
ASD
1	AN04166	24	M	8.1	18.51		Frozen	WM
2	AN03935	19	M	7.0	28		Frozen	WM, GM
3	AN02987	15	M	6.7	30.83		Frozen	WM
4	5144	7	M	8.0	3		Frozen	WM
5	5302	16	M	4.8	20	Risperidone, Fluvoxamine, Clonidine, Insulin	Frozen	WM, GM
6	5176	22	M	5.1	18	Risperdal	Frozen	WM, GM
7	5297	33	M	2.5	50	Quetiapine, Fluoxetine, Divalproex Sodium, ziprasidone	Frozen	WM, GM
8	5027	37	M	4.7	26	Risperidone, Fluvoxamine	Frozen	WM, GM
9	AN11989	30	M	5.7	16.06		Frozen	WM, GM
10	AN07817	19	M	4.5	14.83		Frozen	WM, GM
11	AN00764	20	M	5.9	23.66	Minocycline	Frozen	WM, GM
12	AN04682	15	M	5.6	23.23		Frozen	WM, GM
13	4999	20	M	7.0	14		Frozen	WM, GM
14	5308	4	M	7.0	21		Frozen	WM, GM
17	5565	12	M	7.0	22		Frozen	GM
18	5403	16	M	6.6	35		Frozen	GM
19	5334	11	M	5.1	15		Frozen	GM
	Mean	18.88		6.0	22.30
	SEM	2.11		0.3	2.48
	P‐valuea	0.906		0.403	0.654

ID, identification number; RIN,^, RNA integrity number; PMI,^, postmortem interval; qPCR,^, quantitative real‐time polymerase chain reaction; WM,^, white matter; GM,^, gray matter.

^a P‐value = results of an independent t‐test comparing control and ASD groups, statistically significant when P < 0.05.